Ultra-performance liquid chromatography tandem mass spectrometry for determination of Direct Acting Antiviral drugs in human liver fine needle aspirates.

about

Hepatic Pharmacokinetics and Pharmacodynamics With Ombitasvir/Paritaprevir/Ritonavir Plus Dasabuvir Treatment and Variable Ribavirin Dosage.

P2860

Q47567111-AFF1586E-C110-455C-92F4-56020D0A3F07

P2860

Ultra-performance liquid chromatography tandem mass spectrometry for determination of Direct Acting Antiviral drugs in human liver fine needle aspirates.

Item

http://www.wikidata.org/entity/Q40263873

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Ultra-performance liquid chrom ...... n liver fine needle aspirates.

@en

type

Item

label

Ultra-performance liquid chrom ...... n liver fine needle aspirates.

@en

prefLabel

Ultra-performance liquid chrom ...... n liver fine needle aspirates.

@en

P1476

Ultra-performance liquid chrom ...... n liver fine needle aspirates.

@en

P2093

Andrew H Talal

http://www.w3.org/2001/XMLSchema#string

Andrew J Ocque

http://www.w3.org/2001/XMLSchema#string

Colleen E Hagler

http://www.w3.org/2001/XMLSchema#string

Gene D Morse

http://www.w3.org/2001/XMLSchema#string

Robin DiFrancesco

http://www.w3.org/2001/XMLSchema#string

P2860

Direct anti-HCV agents

Q27023574

Population Pharmacokinetics of Paritaprevir, Ombitasvir, Dasabuvir, Ritonavir, and Ribavirin in Patients with Hepatitis C Virus Genotype 1 Infection: Combined Analysis from 9 Phase 1b/2 Studies

Gene expression analysis in serial liver fine needle aspirates.

Pharmacokinetics and tolerability of paritaprevir, a direct acting antiviral agent for hepatitis C virus treatment, with and without ritonavir in healthy volunteers.

Development and validation of a UPLC-MS/MS method for the simultaneous determination of paritaprevir and ritonavir in rat liver

Fine needle aspiration in the diagnosis of liver neoplasms: a review.

Review article: safety and tolerability of direct-acting anti-viral agents in the new era of hepatitis C therapy.

Performance of hepatitis C virus (HCV) direct-acting antivirals in clinical trials and daily practice.

Metabolism and Disposition of Hepatitis C Polymerase Inhibitor Dasabuvir in Humans.

P304

103-109

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JCHROMB.2017.03.020

http://www.w3.org/2001/XMLSchema#string

P478

1052

http://www.w3.org/2001/XMLSchema#string

P577

2017-03-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28365413

http://www.w3.org/2001/XMLSchema#string

P932

5472061

http://www.w3.org/2001/XMLSchema#string

Ultra-performance liquid chromatography tandem mass spectrometry for determination of Direct Acting Antiviral drugs in human liver fine needle aspirates.

about

P2860

P2860

Ultra-performance liquid chromatography tandem mass spectrometry for determination of Direct Acting Antiviral drugs in human liver fine needle aspirates.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932